BeOne Medicines (BEIGF) Selling, General & Administrative (2015 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Selling, General & Administrative (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 3.41 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -2.87 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | 110.21 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 351.74 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 206.70 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 593.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 593.21 Mn |
| Mar 31, 2026 | 555.10 Mn |
| Dec 31, 2025 | 555.29 Mn |
| Sep 30, 2025 | 529.00 Mn |
| Jun 30, 2025 | 537.91 Mn |
| Mar 31, 2025 | 459.29 Mn |
| Dec 31, 2024 | 504.68 Mn |
| Sep 30, 2024 | 455.22 Mn |
| Jun 30, 2024 | 443.73 Mn |
| Mar 31, 2024 | 427.43 Mn |
| Dec 31, 2023 | 418.39 Mn |
| Sep 30, 2023 | 365.71 Mn |
| Jun 30, 2023 | 395.03 Mn |
| Mar 31, 2023 | 328.50 Mn |
| Dec 31, 2022 | 329.74 Mn |
| Sep 30, 2022 | 322.89 Mn |
| Jun 30, 2022 | 331.40 Mn |
| Mar 31, 2022 | 294.57 Mn |
| Dec 31, 2021 | 306.50 Mn |
| Sep 30, 2021 | 269.23 Mn |